Objective To investigate the effect of statins on plaque regression after acute coronary
syndrome (ACS). Methods We carried out a meta-analysis to assess the change in plaque and …

Aims This study aimed to compare the efficacy of angiotensin receptor‐neprilysin inhibitor (ARNI)
therapy with angiotensin converting enzyme inhibitor or angiotensin receptor blocker (…

Although drug-eluting stents (DES) effectively improve the clinical efficacy of percutaneous
coronary intervention, a high risk of late stent thrombosis and in-stent restenosis also exists …

Myocardial ischemia–reperfusion injury (MIRI) was often observed after surgeries, causing
a lot of suffering to patients. Inflammation and apoptosis were critical determinants during …

Myocardial free wall rupture (MFWR) refers to laceration of the heart ventricle or atria, which
is a rare but fatal complication of acute myocardial infarction (AMI). In this study, we aim to …

Frontiers | High triglyceride–glucose index is associated with poor cardiovascular outcomes
in Chinese acute coronary syndrome patients without diabetes mellitus who underwent …

… Bowen Lou ,1,2 Yongbai Luo,1,2 Haoxuan Zhang,3,4 Haoyu … Copyright © 2022 Bowen Lou
et al. This is an open access … Bowen Lou and Yongbai Luo contributed equally to this work…

Background In patients with acute coronary syndrome (ACS), prolonged dual antiplatelet
therapy (DAPT) may reduce ischemic events and increase the risks of bleeding events …

Patients with low baseline low-density lipoprotein cholesterol (LDL-C) but experiencing
recurrent coronary revascularization events have been rarely investigated. In this retrospective …

Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have been
shown to improve cardiovascular outcomes when added to conventional statin therapy. This …